Vigil Neuroscience, a Sanofi company, is a clinical-stage biotechnology company focused on developing treatments for both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. We are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities in our efforts to develop precision-based therapies to improve the lives of patients and their families.
Company Details
- Employees
- 84
- Address
- 100 Forge Rd,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.vigilneuro.com
- Keywords
- neuroscience and microglia.
- HQ
- Watertown, MA
Vigil Neuroscience Questions
Vigil Neuroscience's website is http://www.vigilneuro.com
Vigil Neuroscience's LinkedIn profile is https://www.linkedin.com/company/vigil-neuroscience
Vigil Neuroscience has
84 employees.
View email and phone details for 84
employees at Vigil Neuroscience.
Vigil Neuroscience's industry is
Biotechnology Research
Vigil Neuroscience's top competitors are
Affini-T Therapeutics,
Remix Therapeutics,
Atlas Venture,
Vertex Pharmaceuticals,
Alnylam Pharmaceuticals,
Abata Therapeutics,
Mariana Oncology,
Beam Therapeutics,
Kymera Therapeutics,
Sanofi.
Vigil Neuroscience's categories are Biotechnology Research
